REFERENCES
- Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359 — 62.
- Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362 — 4.
- Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990; 335: 1 — 3.
- Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, et al. Significance of the serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501 —4.
- Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722–4.
- Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: Impli-cations for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381 —8.
- Damen M, Cuypers HTM, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, et al. Interna-tional collaborative study on the second Eurohep HCV-RNA reference panel. J Virological Methods, 1996; 58: 175 — 85.
- Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, et al. The 5'-terminal sequence of the hepatitis C virus genome. Japan J Exp Med 1990; 60: 167 — 77.
- Chomczynski P, Sacchi N. Single step method RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–9.
- Hemmild I, Dakubu S, Mukkala V-M, Siitari H, Lövgren T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochemistry 1984; 137: 335–43.
- Reid JC, Calvin M. Some new 13-diketones containing the trifluoromethyl group. J Am Chem Soc 1950; 72: 2948 — 52.
- Coste J, Montes B, Reynes J, Peeters M, Segarra C, Vendrell J-P, etal. Comparative evaluation of three assays for the quantitation of human immunodefi-ciency virus type 1 RNA in plasma. J Med Virol 1996; 50: 293 — 302.
- Bukh J, Purcell R, Miller R. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci, 1992; 89: 187 — 91.
- Roth WK, Lee J-H, Mister B, Zeuzem S. Compar-ison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol 1996; 34: 261–4.
- Davis GL, Lau JY-N, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal condi-tions for specimen collection and clinical applica-tion in interferon-treated patients. Hepatology 1994; 19: 1337–41.
- Bresters D, Cuypers HTM, Reesink HW, Mauser-Bunschoten EP, van den Berg HM, Schaasberg WP, et al. Comparison of a quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a con-trolled interferon trial. J Med Virol 1994; 43: 262 — 8.
- Gretch D, Corey L, Wilson J, dela Rosa C, Wilson R, Carithers R, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994; 169: 1219 — 25.
- Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, et al. Quantitative ana-lysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993; 104: 877 — 83.